<DOC>
	<DOCNO>NCT02534753</DOCNO>
	<brief_summary>This Phase 1 , single-dose study evaluate pharmacokinetics intravenous Ascorbic Acid .</brief_summary>
	<brief_title>A Pharmacokinetics Study Intravenous Ascorbic Acid</brief_title>
	<detailed_description>The objective study : 1 . To evaluate single-dose pharmacokinetics AA administer intravenously ( IV ) . 2 . To evaluate safety tolerability AA administer intravenously .</detailed_description>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>Is age 18 45 year , inclusive . Has body mass index ( BMI ) 18 32 kg/m2 . Of sound health ability understand requirement study willing comply study requirement procedure . Participates activity would allow accurate evaluation pharmacokinetics Ascorbic Acid Medical physical condition would allow safe participation and/or accurate evaluation pharmacokinetics Ascorbic Acid Has participate investigational drug study within 30 day prior CRU admission .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>